IperionX (NASDAQ:IPX) Sets New 1-Year Low – Should You Sell?

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report)’s share price reached a new 52-week low on Friday . The company traded as low as $21.60 and last traded at $21.60, with a volume of 2248 shares traded. The stock had previously closed at $21.94.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on IPX. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Friday, July 17th. BTIG Research increased their price target on IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 5th. Roth Capital reissued a “buy” rating on shares of IperionX in a report on Monday, June 8th. Finally, Alliance Global Partners restated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, IperionX presently has an average rating of “Moderate Buy” and a consensus target price of $60.33.

Get Our Latest Stock Analysis on IperionX

IperionX Trading Down 1.7%

The stock’s 50 day simple moving average is $31.26 and its 200-day simple moving average is $36.56. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03.

Insiders Place Their Bets

In other news, CEO Anastasios Arima bought 138,720 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The shares were purchased at an average cost of $3.58 per share, with a total value of $496,617.60. Following the transaction, the chief executive officer directly owned 12,455,502 shares in the company, valued at approximately $44,590,697.16. The trade was a 1.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman Todd Hannigan bought 300,000 shares of the business’s stock in a transaction that occurred on Monday, July 13th. The stock was purchased at an average cost of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the transaction, the chairman owned 26,633,334 shares in the company, valued at $95,613,669.06. This trade represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 1,253,720 shares of company stock worth $4,950,618 over the last three months.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of IPX. GAMMA Investing LLC raised its stake in shares of IperionX by 40.3% in the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after purchasing an additional 483 shares during the last quarter. JPMorgan Chase & Co. purchased a new stake in IperionX in the second quarter valued at approximately $66,000. State of Tennessee Department of Treasury purchased a new stake in IperionX in the fourth quarter valued at approximately $119,000. DV Equities LLC acquired a new position in IperionX in the 4th quarter worth approximately $178,000. Finally, Man Group plc acquired a new position in IperionX in the 4th quarter worth approximately $257,000. 2.76% of the stock is owned by institutional investors and hedge funds.

IperionX Company Profile

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

See Also

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.